First Ebola virus vaccine to protect human beings?

The author reflects on the development of vaccines for Ebola virus disease due to the absence of financial incentives for pharmaceutical companies. It mentions non-human primate models of Ebola virus disease was a vaccine based on a recombinant vesicular stomatitis virus expressing the Ebola virus glycoprotein (rVSV-ZEBOV). It also mentions assessment of the efficacy of a single intramuscular dose of the rVSV-ZEBOV vaccine in the prevention of laboratory confirmed Ebola virus disease.